Quarterly report · Q1
4360.TEDINET S100RGS0
Period2023-04-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.6bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥11.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥89m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥117m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥128m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥152m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥148m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥171m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥116m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥118m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥116m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥118m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥14.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥15.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥13.8bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.7bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.2bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥11.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥14.55 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥103.26 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.97 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 75.1% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.8% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E36769-000Fine Chemical Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥979m |
| jpcrp040300-q1r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥979m |
| jpcrp040300-q1r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥157m |
| jpcrp040300-q1r_E36769-000Flame Retardants Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥194m |
| jpcrp040300-q1r_E36769-000Health Support Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥381m |
| jpcrp040300-q1r_E36769-000Health Support Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥381m |
| jpcrp040300-q1r_E36769-000Health Support Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥31m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥2.6bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥2.6bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥383m |
| jpcrp040300-q1r_E36769-000Fine Chemical Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥938m |
| jpcrp040300-q1r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥938m |
| jpcrp040300-q1r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥105m |
| jpcrp040300-q1r_E36769-000Flame Retardants Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥272m |
| jpcrp040300-q1r_E36769-000Health Support Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥303m |
| jpcrp040300-q1r_E36769-000Health Support Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥303m |
| jpcrp040300-q1r_E36769-000Health Support Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥19m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥2.5bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥2.5bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥397m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 326
| Item | Context | Value | Unit |
|---|---|---|---|
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 5000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 3000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -21000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 60000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 97000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 176000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 97000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 176000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 0 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E36769-000FineChemicalBusinessReportableSegmentsMember | 938000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 1210000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E36769-000HealthSupportBusinessReportableSegmentsMember | 303000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 2452000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E36769-000FineChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E36769-000HealthSupportBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E36769-000FineChemicalBusinessReportableSegmentsMember | 938000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 1210000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E36769-000HealthSupportBusinessReportableSegmentsMember | 303000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 2452000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E36769-000FineChemicalBusinessReportableSegmentsMember | 105000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 272000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E36769-000HealthSupportBusinessReportableSegmentsMember | 19000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 397000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E36769-000FineChemicalBusinessReportableSegmentsMember | 979000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 1246000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E36769-000HealthSupportBusinessReportableSegmentsMember | 381000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 2607000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E36769-000FineChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E36769-000HealthSupportBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E36769-000FineChemicalBusinessReportableSegmentsMember | 979000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 1246000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E36769-000HealthSupportBusinessReportableSegmentsMember | 381000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 2607000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E36769-000FineChemicalBusinessReportableSegmentsMember | 157000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E36769-000FlameRetardantsBusinessReportableSegmentsMember | 194000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E36769-000HealthSupportBusinessReportableSegmentsMember | 31000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 383000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-08-09 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第３期第１四半期（自 2023年４月１日 至 2023年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社マナック・ケミカル・パートナーズ | |
| Company name in english cover page | FilingDateInstant | MANAC Chemical Partners Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役会長兼社長 杉之原 祥二 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |